Back to Journals » ClinicoEconomics and Outcomes Research » Volume 16 » default

ClinicoEconomics and Outcomes Research

COPE logo
ISSN: 1178-6981

Archive: Volume 16, 2024

Actions to Improve the Secondary Prevention of Fragility Fractures in Women with Postmenopausal Osteoporosis: A Social Return on Investment (SROI) Study

Olmo-Montes FJ, Caeiro-Rey JR, Peris P, Pérez del Río V, Etxebarria-Foronda Í, Cancio-Trujillo JM, Pareja T, Jódar E, Naranjo A, Moro-Álvarez MJ, García-Goñi M, Vergés J, Maratia S, Campos Tapias I, Prades M, Aceituno S

ClinicoEconomics and Outcomes Research 2024, 16:889-901

Published Date: 24 December 2024

Budget Impact Analysis of Implementing Patient Blood Management in the Cardiovascular Surgery Department of a Turkish Private Hospital

Tatar M, Akdeniz CS, Zeybey U, Şahin S, Çiftçi Ç

ClinicoEconomics and Outcomes Research 2024, 16:877-887

Published Date: 19 December 2024

Predictive and Interpretable Machine Learning of Economic Burden: The Role of Chronic Conditions Among Elderly Patients with Incident Primary Merkel Cell Carcinoma (MCC)

Mbous YPV, Siddiqui ZA, Bharmal M, LeMasters T, Kolodney J, Kelley GA, Kamal KM, Sambamoorthi U

ClinicoEconomics and Outcomes Research 2024, 16:847-868

Published Date: 11 December 2024

Behavioral Economic Strategies Increase Adverse Event Reporting in Pediatric Anesthesia

Guan TK, Willer BL, Stevens J, Tobias JD, Olbrecht VA

ClinicoEconomics and Outcomes Research 2024, 16:841-845

Published Date: 7 December 2024

Evaluating Service Satisfaction and Sustainability of the Afya Health Insurance Scheme in Kuwait: An Exploratory Analysis [Response to Letter]

Alnashmi M, Bhuiyan NM, AlFaham N, Salman A, AlHumaidi H, Akhtar N

ClinicoEconomics and Outcomes Research 2024, 16:839-840

Published Date: 21 November 2024

Characteristics of High-Cost Beneficiaries of Prescription Drugs in Kazakhstan: A Cross-Sectional Study of Outpatient Data from 2022

Nazarbayev A, Nurbakyt A, Omirbayeva B, Akhmetzhan A, Kosherbayeva L

ClinicoEconomics and Outcomes Research 2024, 16:827-837

Published Date: 13 November 2024

Cost Analysis of Thromboprophylaxis in Patients at High Thromboembolic Risk with Enoxaparin, Dalteparin and Nadroparin in Colombia: A Systematic Literature Review-Based Study

Rojas-Suarez J, Gutiérrez Clavijo JC, Zakzuk J, López JF, Silva Gomez L, Londoño Gutiérrez S, Alvis-Zakzuk NJ

ClinicoEconomics and Outcomes Research 2024, 16:813-825

Published Date: 8 November 2024

Economic Evaluation of Once-Weekly Insulin Icodec from Italian NHS Perspective

Torre E, Di Matteo S, Bruno GM, Martinotti C, Bottaro LC, Colombo GL

ClinicoEconomics and Outcomes Research 2024, 16:799-811

Published Date: 6 November 2024

Cost-Utility of Real-Time Continuous Glucose Monitoring versus Self-Monitoring of Blood Glucose in People with Insulin-Treated Type 2 Diabetes in Spain

Merino-Torres JF, Ilham S, Alshannaq H, Pollock RF, Ahmed W, Norman GJ

ClinicoEconomics and Outcomes Research 2024, 16:785-797

Published Date: 5 November 2024

Economic Impact of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in Italy. Analysis and Perspectives

Torre E, Di Matteo S, Martinotti C, Bruno GM, Goglia U, Testino G, Rebora A, Bottaro LC, Colombo GL

ClinicoEconomics and Outcomes Research 2024, 16:773-784

Published Date: 24 October 2024

Estimating Costs Associated with Adverse Events in Patients with Advanced Lung Cancer

Lin CY, Wu TI, Yang SC

ClinicoEconomics and Outcomes Research 2024, 16:761-769

Published Date: 19 October 2024

Economic Burden, Length of Hospital Stay and Complication of Simultaneous versus Staged Bilateral Hip Arthroplasty: A Hospital Prospective Study

Shen M, Jiang W, Qian P, Cai G, Wu X, Wang J, Ning X, Song L

ClinicoEconomics and Outcomes Research 2024, 16:753-760

Published Date: 17 October 2024

Improving Adherence and Reducing Health Care Costs Through Blister-Packaging: An Economic Model for a Commercially Insured Health Plan

Borrelli EP, Saad P, Barnes NE, Dumitru D, Lucaci JD

ClinicoEconomics and Outcomes Research 2024, 16:733-745

Published Date: 3 October 2024

Consideration for Health Disparities in Value Assessment Frameworks

Seo D, Patil D, Vandigo J, Mattingly II TJ

ClinicoEconomics and Outcomes Research 2024, 16:721-731

Published Date: 28 September 2024

A Mixed-Method Study of Medication-Related Burden Among Multi-Drug Resistant Tuberculosis Patients in West Java, Indonesia

Ausi Y, Yunivita V, Santoso P, Sunjaya DK, Barliana MI, Ruslami R

ClinicoEconomics and Outcomes Research 2024, 16:707-719

Published Date: 24 September 2024

Automated Drugs Dispensing Systems in Hospitals: a Health Technology Assessment (HTA) Study Across Six European Countries

Foglia E, Asperti F, Antonacci G, Jani YH, Garagiola E, Bellavia D, Ferrario L

ClinicoEconomics and Outcomes Research 2024, 16:679-696

Published Date: 20 September 2024

Adjusting Historical Costs for Inflation with the Use of Standardized Automated Tools

Guertin JR, Chouinard NH, Forget A, Blais L

ClinicoEconomics and Outcomes Research 2024, 16:675-678

Published Date: 14 September 2024

Homologous Recombination Repair Testing Patterns and Outcomes in mCRPC by Alteration Status and Race

Bilen MA, Khilfeh I, Rossi C, Muser E, Morrison L, Hilts A, Diaz L, Lefebvre P, Pilon D, George DJ

ClinicoEconomics and Outcomes Research 2024, 16:657-674

Published Date: 6 September 2024

Evaluating Service Satisfaction and Sustainability of the Afya Insurance Scheme in Kuwait: An Exploratory Analysis

Alnashmi M, Bhuiyan NM, AlFaham N, Salman A, AlHumaidi H, Akhtar N

ClinicoEconomics and Outcomes Research 2024, 16:597-617

Published Date: 23 August 2024

Health Equity Considerations in Cost-Effectiveness Analysis: Insights from an Umbrella Review

Muir JM, Radhakrishnan A, Ozer Stillman I, Sarri G

ClinicoEconomics and Outcomes Research 2024, 16:581-596

Published Date: 20 August 2024

Clinical and Economic Impact of Early Diagnosis of Chronic Kidney Disease in General Practice: The Endorse Study

Pesce F, Bruno GM, Colombo GL, Di Matteo S, Maurizi AR, Mongelli V, Mele S, Narici L, Bianchi S, Bonomini M, Castellano G, De Nicola L, Gambaro G, Grandaliano G, La Manna G, Pani A, Ranghino A, Gesualdo L

ClinicoEconomics and Outcomes Research 2024, 16:547-555

Published Date: 5 August 2024

Health Technology Assessment for Fast-Track Elective Knee and Hip Arthroplasty in a High-Volume Orthopaedic Hospital in Italy

Restelli U, Vitale J, Croce E, Bernareggi S, Guida S, Silvola S, Banfi G, Zagra L

ClinicoEconomics and Outcomes Research 2024, 16:537-545

Published Date: 5 August 2024

Assessment of Direct Medical Cost of Hospitalized COVID-19 Adult Patients in Kuwait During the First Wave of the Pandemic

AlManie SA, AlHazami MS, Ebrahim A, Attique MS

ClinicoEconomics and Outcomes Research 2024, 16:509-522

Published Date: 24 July 2024

Modelling the Costs of Sublingual Immunotherapy versus Subcutaneous Immunotherapy Based on Clinical Appointments and Impacts of Patient Travel in Sweden

Cardell LO, Sterner T, Ahmed W, Slættanes AK, Svärd M, Pollock RF

ClinicoEconomics and Outcomes Research 2024, 16:493-506

Published Date: 10 June 2024

Cost-Effectiveness Analysis of the Oncotype DX Breast Recurrence Score® Test from a US Societal Perspective

Berdunov V, Cuyun Carter G, Laws E, Luo R, Russell CA, Campbell S, Abdou Y, Force J

ClinicoEconomics and Outcomes Research 2024, 16:471-482

Published Date: 4 June 2024

Development of an Efficient and Effective Clinical Pathway for Cesarean Section in West Sumatra (Indonesia)

Aladin A, Taifur WD, Aljunid SM, Ocviyanti D

ClinicoEconomics and Outcomes Research 2024, 16:461-469

Published Date: 30 May 2024

Oral Prostacyclin Pathway Agents Used in PAH: A Targeted Literature Review

Burger CD, Tsang Y, Chivers M, Vekaria RV, Doad G, Atkins N, Panjabi S

ClinicoEconomics and Outcomes Research 2024, 16:447-459

Published Date: 30 May 2024

Clinical and Economic Value of a Biosimilar Portfolio to Stakeholders: An Integrative Literature Review

Fox GE, Bernauer M, Stephens JM, Jackson B, Roth JA, Shelbaya A

ClinicoEconomics and Outcomes Research 2024, 16:247-416

Published Date: 13 May 2024

Expanding Access to Patient Care in Community Pharmacies for Minor Illnesses in Washington State

Akers JM, Miller JC, Seignemartin B, MacLean LG, Mandal B, Kogan C

ClinicoEconomics and Outcomes Research 2024, 16:233-246

Published Date: 3 May 2024

Cost-Utility Analysis Comparing Pegcetacoplan to Anti-C5 Monoclonal Antibodies in the Treatment of Paroxysmal Nocturnal Hemoglobinuria

Di Matteo S, Freilone R, Bruno GM, Notaro R, Moumene S, Martone N, Teruzzi C, Ciccarone A, Colombo GL

ClinicoEconomics and Outcomes Research 2024, 16:225-232

Published Date: 11 April 2024

Cost-Savings Associated with Multi-Disciplinary Team Approach for Reducing Macrovascular and Microvascular Complications in Patients with Type 2 Diabetes: A Predictive Model

Alshowair A, Altamimi S, Alruhaimi FA, Alshahrani S, Alsuwailem F, Alkhaldi M, Abdalla H, Alkhuraiji FH, Alaqeel MS, Almureef SS, Alhawasy S, Abdel-Azeem A

ClinicoEconomics and Outcomes Research 2024, 16:211-223

Published Date: 4 April 2024

Evaluating Health Expenditure Trends and Disease Burden in India: A Cost per DALY Approach

Bagepally BS, Kumar S S, Sasidharan A

ClinicoEconomics and Outcomes Research 2024, 16:187-196

Published Date: 26 March 2024

Key Performance Indicators: A Framework for Allied Healthcare Educational Institutions

Sreedharan JK, Subbarayalu AV, Kamalasanan A, Albalawi I, Krishna GG, Alahmari AD, Alsalamah JA, Alkhathami MG, Alenezi M, Alqahtani AS, Alahmari M, Phillips MR, MacDonald J

ClinicoEconomics and Outcomes Research 2024, 16:173-185

Published Date: 26 March 2024

The Economic Burden of Diabetic Retinopathy in Jordan: Cost Analysis and Associated Factors

Al-Dwairi RA, Aleshawi A, Abu-zreig L, Al-Shorman W, Al Beiruti S, Alshami AO, Allouh MZ

ClinicoEconomics and Outcomes Research 2024, 16:161-171

Published Date: 15 March 2024

Medical Costs Associated with High/Moderate/Low Likelihood of Adult Growth Hormone Deficiency: A Healthcare Claims Database Analysis

Yuen KC, Blevins LS, Clemmons DR, Faurby M, Hoffman AR, Kelepouris N, Kerr JM, Tarp JM, Fleseriu M

ClinicoEconomics and Outcomes Research 2024, 16:133-147

Published Date: 8 March 2024

The Economic Impact of Obesity in Turkey: A Micro-Costing Analysis

Gogas Yavuz D, Akhtar O, Low K, Gras A, Gurser B, Yilmaz ES, Basse A

ClinicoEconomics and Outcomes Research 2024, 16:123-132

Published Date: 5 March 2024

The Economic Burden of the COVID-19 Pandemic in State of Kuwait

Nur AM, Aljunid SM, Almari M

ClinicoEconomics and Outcomes Research 2024, 16:111-122

Published Date: 4 March 2024

Comparative Costs to Medicare and Medicare Beneficiaries of Alternative AF Stroke Risk Reduction Strategies

Reddy VY, Zhong Y, McGovern AM, Amorosi SL, Gavaghan MB, Hertz DS, Low K, Freeman S, Holmes DR Jr

ClinicoEconomics and Outcomes Research 2024, 16:81-96

Published Date: 14 February 2024

Pharmacoeconomic Evaluation of Costs of Myelomeningocele and Meningocele Treatment and Screening

Hoxha M, Malaj V, Zappacosta B, Firza N

ClinicoEconomics and Outcomes Research 2024, 16:69-80

Published Date: 9 February 2024

Disutility of Cognitive Processing Speed (CPS) Impairment in the Context of Multiple Sclerosis: A Time Trade-Off (TTO) Elicitation Study

Benedict RH, Vo P, Adlard N, Grennan O, Enstone A, Bridge D, Wyn R, Cohan SL

ClinicoEconomics and Outcomes Research 2024, 16:55-67

Published Date: 8 February 2024

Methods used to account for caregivers’ sex and gender within studies examining the financial burden of caregivers of children and adolescents : Results from a scoping review

Guertin JR, Gilbert-Ouimet M, Dugas M, Carnovale V, Jalbert L, Svyntozelska O, Demers J, Matteau L, Bergeron F, LeBlanc A

ClinicoEconomics and Outcomes Research 2024, 16:35-53

Published Date: 26 January 2024

The Cost-Effectiveness of Dolutegravir in Combination with Tenofovir and Lamivudine for HIV Therapy: A Systematic Review

Aprilianti S, Utami AM, Suwantika AA, Zakiyah N, Azis VI

ClinicoEconomics and Outcomes Research 2024, 16:25-34

Published Date: 26 January 2024

Budget Impact Analysis of Minimally Invasive versus Open Transforaminal Lumbar Interbody Fusion for Lumbar Degenerative Disease: A European Hospital Perspective

Bassani R, Galvain T, Battaglia S, Maheswaran H, Wright G, Kambli A, Piemontese A

ClinicoEconomics and Outcomes Research 2024, 16:13-24

Published Date: 18 January 2024

Exploring the Cost-Utility of a Biomarker Predicting Persistent Severe Acute Kidney Injury: The Case of C-C Motif Chemokine Ligand 14 (CCL14)

Echeverri J, Martins R, Harenski K, Kampf JP, McPherson P, Textoris J, Koyner JL

ClinicoEconomics and Outcomes Research 2024, 16:1-12

Published Date: 12 January 2024